Diabetes drug may boost heart fuel use in patients with clogged arteries
NCT ID NCT03313752
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether dapagliflozin, a diabetes medication, can improve how the heart uses sugar and blood flow in people with type 2 diabetes and stable coronary artery disease. 25 adults took either the drug or a placebo for 4 weeks. The goal was to see if the drug helps the heart work better, not to cure diabetes or heart disease. Participants continued their usual diabetes care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STABLE CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Center For Endocrine and Metabolic Diseases - Catholic University
Rome, RM, 00168, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single shot stop clots? a new drug puts the idea to the test
- Daily pill aims to tackle weight and diabetes together
- Mind over matter: relaxation techniques aim to ease heart Patients' anxiety
- New pill for diabetes and kidney disease enters first human tests
- Tiny study probes how heart rebounds after brief artery blockage
- Could a common diabetes pill protect your heart?